The company announced the closures Nov. 6 in a regulatory filing. The locations of the stores have not yet been disclosed.
CVS Health recorded a $96 million impairment charge on its third-quarter earnings related to the 22 stores it plans to close, according to CNBC. It recorded a $135 million charge in the first quarter related to the 46 stores it closed earlier this year.
Drugstores have struggled as consumers buy more pharmacy products online and new competitors sell prescriptions online. Walgreens announced earlier this year that it plans to close 200 stores in the U.S. and 200 in the U.K., along with all of its self-owned in-store health clinics.
CVS executives have said they do not expect “meaningful” store closures, according to CNBC.
Read the full article here.
More articles on pharmacy:
Amgen exits neuroscience research, cuts 180 US jobs
Walgreens’ exit from health clinic business should serve as a warning to rivals
Top 10 pharmacy stories in October
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
